confirmed that human TMEM176A and 176B protein levels were significantly elevated in lymphoma and lung carcinoma but not in normal tissues, which substantiated that TMEM176A and 176B could be potential biomarkers for some human cancers (38). This evidence concerns the gene TMEM176A and lung carcinoma.